TABLE 2.
Patient survey responses for indication of non‐statin LLT
| Non‐statin LLT overall a | Fish oil | Fibrate | Ezetimibe | Niacin | |
|---|---|---|---|---|---|
| Bad cholesterol too high | 61.0% | 57.8% | 69.0% | 76.9% | 59.0% |
| Triglyceride too high | 39.6% | 34.2% | 63.5% | 43.4% | 42.5% |
| Good cholesterol too high | 20.3% | 18.3% | 25.2% | 24.5% | 38.1% |
| Prevent stroke | 27.3% | 28.7% | 21.7% | 34.4% | 29.9% |
| Prevent heart attack | 38.9% | 41.9% | 28.6% | 42.9% | 45.5% |
| Family history | 32.2% | 31.7% | 34.5% | 33.0% | 32.8% |
| Do not know | 11.1% | 12.4% | 6.2% | 10.9% | 11.9% |
a
Among patients who could be linked with survey data including: 1187/1249 patients treated with fish oil, 396/417 patients treated with fibrate, 314/329 patients treated with ezetimibe and 186/196 patients treated with niacin.